Mitsubishi Pharma Acquires NeuroDerm for Parkinson’s Drug
By Jawala Prasad
Pharma Deals Review: Vol 2017 Issue 8 (Table of Contents)
Published: 24 Aug-2017
DOI: 10.3833/pdr.v2017.i8.2269 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Mitsubishi Tanabe Pharma entered into an agreement to acquire Israel-based NeuroDerm for US$39 per share in cash that values the company at US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS